Management ChangeMay 18, 2026, 04:37 PM
60 Degrees Pharma Appoints Eric Francois to Board
AI Summary
60 Degrees Pharmaceuticals, Inc. announced the appointment of Eric Francois to its Board of Directors, effective May 13, 2026. Mr. Francois is a strategic financial executive with over 20 years of leadership experience in the healthcare and life sciences sectors. His extensive background includes roles as a Managing Director in healthcare investment banking at Raymond James and Credit Suisse, and as Chief Financial Officer of SCYNEXIS, Inc., where he raised over $300 million in capital. He also serves as an independent director for other life sciences companies.
Key Highlights
- Eric Francois appointed to 60 Degrees Pharmaceuticals' Board of Directors, effective May 13, 2026.
- Mr. Francois brings over 20 years of leadership experience in healthcare and life sciences.
- He currently serves as an Independent Director of CERo Therapeutics Holdings, Inc.
- Previously, he was a Managing Director in Healthcare Investment Banking at Raymond James and Credit Suisse.
- He served as CFO of SCYNEXIS, Inc., raising over $300 million in capital.
- Mr. Francois also held independent director roles at Diffusion Pharmaceuticals Inc.
Price Impact
More from SXTP